Large-scale testing (Phase 3)Study completedNCT03518086
What this trial is testing
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 1,281